In this study, a series of 14 Cu (II), Zn (II), Ni (II) and Ag (I) complexes containing bis-benzimidazole derivatives were successfully designed and synthesized from 2-(1 H -benzimidazole-2-yl)-phenol derivatives and corresponding metal salt solutions. The compound structures were identified by FT-IR, 1 H-NMR, powder X-ray diffraction and ESI-MS analyses, and the presence of the metal in the complexes was confirmed by ultraviolet-visible spectroscopy and ICP optical emission spectrometry. Electronic structure calculations were also carried out to describe the detailed structures in addition to the electronic absorption spectra of the ligands. The cytotoxic activity of the complexes was evaluated against three human cancer cell lines: lung (A549), breast (MDA-MB-231) and prostate (PC3) cancer cells. All complexes inhibited anti-proliferative cancer cells better than free ligands, especially Zn (II) and Ag (I) complexes, which are most sensitive to MDA-MB-231 cells. In addition, showing the growth inhibition of three cancer cell lines with IC 50 < 10.4 µM, complexes
C
1 ,
C
3 and
C
14 could be considered potential multi-targeted anti-cancer agents.
The detection of lead ions (Pb2+) in water is of critical importance due to the harmful effects of lead on human health and the environment. Traditional detection methods often require high user expertise, expensive equipment, and complex analytical procedures. Electrochemical sensors have emerged as effective alternatives due to their portability and affordability. In this study, a novel electrochemical sensor was developed for the sensitive and selective detection of Pb2+ based on glassy carbon electrodes (GCE) modified with bimetallic metal–organic frameworks (MOFs) and reduced graphene oxide (rGO). The bimetallic MOFs were successfully synthesized via a hydrothermal method, combining two metal centers Fe and Mg linked to a 1,4-benzene dicarboxylate ligand (FeMg-BDC). The synthesized FeMg-BDC has higher conductivity and surface area than monometallic Fe-BDC or Mg-BDC MOFs. Thanks to the synergistic effects between FeMg-BDC and rGO, the rGO/FeMg-BDC electrode has a larger electrochemically active surface area and faster electron transfer rate than the bare GCE. This enhancement facilitated the accumulation of lead onto the electrode surface, thereby improving the sensitivity of Pb2+ ion detection. Using the square wave anodic stripping voltammetry method, the sensor based on rGO/FeMg-BDC electrode exhibited two linear ranges: 0.01 to 0.5 μg L−1 and 0.5 to 50.0 μg L−1, with a low limit of detection (LOD) of 9 ng L−1. Furthermore, the external rGO thin film protects the FeMg-BDC material on the electrode surface, ensuring high durability and repeatability of the sensor. The developed sensor was successfully applied to accurately determine lead ion concentrations in various real water samples.
Improving lipophilicity for drugs to penetrate the lipid membrane and decreasing bacterial and fungal coinfections for patients with cancer pose challenges in the drug development process. Here, a series of new N-alkylated-2-(substituted phenyl)-1H-benzimidazole derivatives were synthesized and characterized by 1H and 13C NMR, FTIR, and HRMS spectrum analyses to address these difficulties. All the compounds were evaluated for their antiproliferative, antibacterial, and antifungal activities. Results indicated that compound 2g exhibited the best antiproliferative activity against the MDA-MB-231 cell line and also displayed significant inhibition at minimal inhibitory concentration (MIC) values of 8, 4, and 4 μg mL-1 against Streptococcus faecalis, Staphylococcus aureus, and methicillin-resistant Staphylococcus aureus compared with amikacin. The antifungal data of compounds 1b, 1c, 2e, and 2g revealed their moderate activities toward Candida albicans and Aspergillus niger, with MIC values of 64 μg mL-1 for both strains. Finally, the molecular docking study found that 2g interacted with crucial amino acids in the binding site of complex dihydrofolate reductase with nicotinamide adenine dinucleotide phosphate.
In order to explore and develop new anticancer agents, three series of 2-phenylbenzimidazoles, 15–46, were condensed under simple and mild conditions using sodium metabisulfite as an oxidation agent and another series, 47–55, were obtained via a reduction reaction using sodium borohydride. All the compounds synthesized were evaluated for their in vitro anticancer activities against three human cancer cell lines. The novel compound 38 was found to be the most potent multi cancer inhibitor against A549, MDA-MB-231, and PC3 cell lines (IC50 values 4.47, 4.68 and 5.50 μg mL−1, respectively). In addition, compound 40 exhibited the best IC50 value of 3.55 μg mL−1 against the MDA-MB-231 cell line. The results demonstrated that introducing a new substituent to compounds 37–55 could improve their antiproliferative activities.